$1.50
0.66% today
Nasdaq, Apr 01, 06:41 pm CET
ISIN
US59503A1051
Symbol
MBOT
Sector
Industry

Microbot Medical Inc Stock price

$1.51
+0.10 7.09% 1M
+0.62 68.90% 6M
+0.39 34.82% YTD
+0.18 13.53% 1Y
-4.76 75.92% 3Y
-4.04 72.79% 5Y
-1,650.89 99.91% 10Y
Nasdaq, Closing price Mon, Mar 31 2025
+0.05 3.42%
ISIN
US59503A1051
Symbol
MBOT
Sector
Industry

Key metrics

Market capitalization $52.46m
Enterprise Value $47.05m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 8.30
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-11.63m
Free Cash Flow (TTM) Free Cash Flow $-8.85m
Cash position $5.52m
EPS (TTM) EPS $-0.73
P/S forward 8.74
EV/Sales forward 7.84
Short interest 14.81%
Show more

Is Microbot Medical Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Microbot Medical Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Microbot Medical Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Microbot Medical Inc:

Buy
100%

Financial data from Microbot Medical Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
- -
-
100%
- Direct Costs 0.09 0.09
18% 18%
-
-0.09 -0.09
18% 18%
-
- Selling and Administrative Expenses 4.90 4.90
22% 22%
-
- Research and Development Expense 6.54 6.54
16% 16%
-
-12 -12
18% 18%
-
- Depreciation and Amortization 0.09 0.09
18% 18%
-
EBIT (Operating Income) EBIT -12 -12
18% 18%
-
Net Profit -11 -11
7% 7%
-

In millions USD.

Don't miss a Thing! We will send you all news about Microbot Medical Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Microbot Medical Inc Stock News

Neutral
GlobeNewsWire
about 5 hours ago
Company Reaffirms Expected Timing of FDA Decision With Respect to 510(K) Clearance of LIBERTY® During the Current Second Quarter Company Reaffirms Expected Timing of FDA Decision With Respect to 510(K) Clearance of LIBERTY® During the Current Second Quarter
Neutral
GlobeNewsWire
28 days ago
Mr. Paul Mullen Most Recently Served as the Director of Sales at Inari Medical which was Acquired by Stryker Corporation Earlier This Year
Neutral
GlobeNewsWire
about one month ago
BRAINTREE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, today announced its collaboration with Corewell Health™ has reached another meaningful milestone.
More Microbot Medical Inc News

Company Profile

Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.

Head office United States
CEO Harel Gadot
Employees 21
Founded 1988
Website microbotmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today